Schroder Investment Management Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-685,315
Closed -$5.35M 1224
2024
Q2
$5.35M Buy
+685,315
New +$5.08M 0.01% 768
2023
Q2
Sell
-492,966
Closed -$3.08M 1249
2023
Q1
$3.08M Sell
492,966
-60,363
-11% -$337K ﹤0.01% 871
2022
Q4
$2.58M Sell
553,329
-254,216
-31% -$1.25M ﹤0.01% 904
2022
Q3
$3.77M Buy
807,545
+278,555
+53% +$1.76M 0.01% 830
2022
Q2
$3.33M Buy
528,990
+352,573
+200% +$3.92M 0.01% 876
2022
Q1
$3.35M Buy
+176,417
New +$4.05M ﹤0.01% 929

Other funds holding GDRX

Schroder Investment Management Group's GDRX Position: Q3 2024 in Review

Schroder Investment Management Group sold out of GoodRx Holdings (GDRX) in Q3 2024, closing a stake of 685,315 shares — an estimated $5.35M sold.

Schroder Investment Management Group first reported a position in GDRX in Q1 2022 and held it in 6 quarters. The position peaked at $5.35M in Q2 2024. 168 funds tracked by Wall St. Rank hold GDRX as of Q3 2024.

  • Schroder Investment Management Group reported no remaining GoodRx Holdings position as of Q3 2024 after selling out during the quarter.
  • Schroder Investment Management Group sold 685,315 GoodRx Holdings shares in Q3 2024, an estimated $5.35M.
  • Schroder Investment Management Group first reported a position in GoodRx Holdings in Q1 2022 and held it in 6 quarters.
  • Schroder Investment Management Group's GoodRx Holdings position peaked at $5.35M in Q2 2024.
  • 168 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2024.

Based on Schroder Investment Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.